Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 9/20 | 0.62 |
| ▸ | PPARD | Q03181 | 9/20 | 0.62 |
| ▸ | PPARA | Q07869 | 9/20 | 0.62 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.51 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.51 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6937885 | 0.92 | PPARG (0.73) | PPARGPPARDPPARACYSLTR2CYSLTR1 | |
| SCHEMBL6936685 | 0.91 | PPARG (0.64) | PPARGPPARDPPARACYSLTR2CYSLTR1 | |
| SCHEMBL6936040 | 0.91 | PPARG (0.63) | PPARGPPARDPPARACYSLTR2CYSLTR1 | |
| SCHEMBL6938282 | 0.90 | PPARG (0.69) | PPARGPPARDPPARACYSLTR2CYSLTR1 | |
| SCHEMBL6938970 | 0.90 | PPARG (0.75) | PPARGPPARDPPARACYSLTR2CYSLTR1 | |
| SCHEMBL6938100 | 0.88 | PPARG (0.69) | PPARGPPARDPPARACYSLTR2CYSLTR1 | |
| SCHEMBL6933140 | 0.86 | PPARG (0.59) | PPARGPPARDPPARACYSLTR2CYSLTR1 | |
| SCHEMBL6937189 | 0.86 | PPARG (0.84) | PPARGPPARDPPARACYSLTR2CYSLTR1 | |
| SCHEMBL6936461 | 0.84 | PPARG (0.59) | PPARGPPARDPPARACYSLTR2CYSLTR1 | |
| SCHEMBL6936707 | 0.83 | PPARG (0.50) | PPARGPPARDPPARACYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888278-B1 | ANTIDIABETIC AGENTS | MERCK & CO INC (US) | 2003-07-23 | — | — | EP | claimed |